
Microsys Pharmaceuticals Private Limited
About Microsys Pharmaceuticals Private Limited
Data last updated:
Microsys Pharmaceuticals Private Limited was a private limited company based in Hathras, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the service-based operations segment of the business services sector. It was incorporated on 14 March 2018.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2018PTC101984. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was led by directors including Pawan Kumar Agrawal and Dilip Kumar Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at Nagariya Nandram Kota Road, Hathras, Uttar Pradesh, India – 204101.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.9 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹1.14 Lakh (net margin -19.3%) and EBITDA of -₹1.12 Lakh (EBITDA margin -19%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
Company details
Contact details
Microsys Pharmaceuticals Private Limited's registered office is in Hathras, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressNagariya Nandram Kota Road, Hathras, Uttar Pradesh, India – 204101
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Microsys Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Microsys Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Microsys Pharmaceuticals Private Limited, buy the company report.
Financials of Microsys Pharmaceuticals Private Limited
FY 2022 filings availableMicrosys Pharmaceuticals Private Limited reported revenue of ₹5.9 Lakh (down 9% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 9% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.14 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -19% | ||||
| Net Profit Margin | -19.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Microsys Pharmaceuticals Private Limited, buy the company report.
Board of directors of Microsys Pharmaceuticals Private Limited
Microsys Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Kumar Agrawal | Director | 14 Mar 2018 | 8 Years 8 Months | As last reported |
| Dilip Kumar Agrawal | Director | 14 Mar 2018 | 8 Years 8 Months | As last reported |
| Rajat Jindal | Director | 14 Mar 2018 | 8 Years 8 Months | As last reported |
| Santosh Sharma | Director | 12 Apr 2018 | 8 Years 7 Months | As last reported |
Peer comparison
Microsys Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riedeli Pharmaceuticals Private Limited | ₹5.95 Lakh (FY 2024) | -1.0% | Allahabad, Uttar Pradesh, India | |||
| Denice Pharmaceuticals Private Limited | ₹5.92 Lakh (FY 2022) | 91.0% | Jabalpur, Madhya Pradesh, India | |||
| Microsys Pharmaceuticals Private Limitedthis company | ₹5.9 Lakh (FY 2022) | -₹1.14 Lakh | -19.3% | -9.0% | Hathras, Uttar Pradesh, India | |
| Gyrus Pharmaceuticals Private Limited | ₹5.85 Lakh (FY 2025) | 21.0% | Amritsar, Punjab, India | |||
| Maclaren Pharmaceuticals Private Limited | ₹5.84 Lakh (FY 2022) | -16.0% | Bareilly, Uttar Pradesh, India |
To see the full peer comparison of Microsys Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Microsys Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Microsys Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Microsys Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Microsys Pharmaceuticals Private Limited, buy the company report.
Recent activity
Microsys Pharmaceuticals Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Santosh Sharma ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Microsys Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Microsys Pharmaceuticals was a private limited company based in Hathras, Uttar Pradesh, India. The company worked in other services, within the business services industry. It was incorporated on 14 March 2018 and is registered under CIN U74999UP2018PTC101984. The company has been struck off by the Registrar of Companies and is no longer operational.
Microsys Pharmaceuticals had 4 directors:
- Pawan Kumar Agrawal - Director
- Dilip Kumar Agrawal - Director
- Rajat Jindal - Director
- Santosh Sharma - Director
The CIN (Corporate Identification Number) of Microsys Pharmaceuticals is U74999UP2018PTC101984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Microsys Pharmaceuticals is at Nagariya Nandram Kota Road, Hathras, Uttar Pradesh, India – 204101.
Microsys Pharmaceuticals was incorporated on 14 March 2018. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Microsys Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
No. Microsys Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Microsys Pharmaceuticals operated in the business services industry, in the other services segment. It worked in this industry before it was struck off.
The peers of Microsys Pharmaceuticals by revenue are Riedeli Pharmaceuticals Private Limited, Denice Pharmaceuticals Private Limited, Gyrus Pharmaceuticals Private Limited, Maclaren Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Santosh Sharma ceased to be Additional Director on 30 Sep 2019. Santosh Sharma was appointed as Director on 12 Apr 2018. Dilip Kumar Agrawal was appointed as Director on 14 Mar 2018. Microsys Pharmaceuticals has 5 board changes on record in total.

